Investments in linker and conjugation technologies have become the single-biggest area of investments within the ADC field, showing how they are being used as key levers for ADC drug developers […]

Bringing together technical experts from biopharma and academia, the brand-new RNA Assay Development & Screening Summit has been curated to support in-house assay development and screening strategies to find new RNA targets, and ultimately […]

Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE. This decade of success has resulted in explosive investment into the development of […]

Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression. The prospect of defining impurities and suitable CQAs for […]

The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire […]

The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of […]

The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with likeminded peers from gene therapy drug developers, along with leading academics, regulators, and key service providers, all […]

The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically […]

With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for its 7th year in a timely fashion. Be the first to view this […]

Fingerprinting Your LNP Drug Product Quality, Safety, Efficacy & Regulatory Compliance With the recent breakthroughs from Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA […]

Your one-stop shop to capturing industry’s most exciting developments to tackle rare & genetic kidney diseases. From evaluating real-world outcomes to uncovering underlying pathophysiology to interrogating translational models, the 3rd […]

Wearable Injectors and Connected Devices USA Conference: September, 13 – 14 2023 Boston, USA Website: http://www.wearableinjectors-usa.com/PharmaJournalist-EL Advancing digital health and on-body drug delivery devices for enhanced patient experience Following the […]

FIbroGen’s recent Phase 3 trial failure for pamrevlumab exemplifies the critical time point the pulmonary fibrosis field is currently at as drug developers move through in-human to Phase 2 to […]

Returning to Boston as the world’s only industry-leading meeting focused on mRNA process development and manufacturing, join 200+ VPs, Directors and Heads of Process Development, MSAT, Technical Operations, CMC and […]

With the first commercial TIL therapy brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, the race is on for the next […]

Wearable Injectors and Connected Devices Conference & Expo 9 – 10 October 2023 | London, UK http://www.wearable-injectors.co.uk/PharmaJournalist-EL Strategies to advance digital health and on-body drug devices for large volume delivery […]

The Definitive Industry Forum for Spearheading Non-Psychedelic & Psychedelic R&D 2023 is booming with novel psychiatric R&D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum, […]

The ADC renaissance shows no sign of slowing down with the ground-breaking approval of ELAHERE for platinum resistant ovarian cancer, Pfizer’s jaw-dropping acquisition of Seagen for $43 billion, and BMS’ […]

The Early Access Programmes Summit Europe returns for a second year this October, aiming to help the industry navigate the notoriously complex European regulatory landscape, and conquer operational hurdles to provide […]

Scaling Flow Chemistry for Sustainability, Safety and Speed to Market  With the growing demand for better flow technology, the 4th Commercializing Flow Chemistry Summit is your must-attend meeting to deep-dive into […]

The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-shelf, solid […]

Returning for its 11th year, the IMPACCT: Real World Evidence Summit 2023 will deep dive into the use of RWE for regulatory submissions and clinical trial innovation to unlock unstructured […]

Biosensors for Medical Wearables Conference and Expo *In collaboration with Medical Design Briefs* October 23-24, 2023 | Boston, MA, USA http://www.biosensors-medical-wear.com/PharmaJournalist-WL SAE Media Group’s 3rd Annual Biosensors for Medical Wearables […]

CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm takes place, more complex CRISPR structures […]

Accelerating More Transformative Gene Therapies for CNS Disorders Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene […]

Join us at this year's much-anticipated Extractables and Leachables Europe, taking place on 6-7 November 2023 in Amsterdam. This year's conference promises to once again provide you with everything you […]

PURIFY – Chromatography Purification Conclave PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups! The pharmaceutical industry continues to […]

The 7th Microbiome Movement – Human Nutrition Summit will unite 100+ human nutrition leaders this November in Livingston, NJ to optimize product development and consumer acceptance of microbiome-based food and […]

Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, […]

Eli Lilly’s ‘triple G’ drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up to 24% weight loss, a new record for […]